Total Payments
$397.84
2024 Payments
$46.10
Companies
11
Transactions
15
Medicare Patients
7,250
Medicare Billing
$849,100
Payment Breakdown by Category
Food & Beverage$397.84 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $397.84 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $91.67 | 3 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $76.42 | 1 | $0 (2017) |
| Veloxis Pharmaceuticals, Inc. | $49.91 | 2 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $41.62 | 1 | $0 (2022) |
| Shire North American Group Inc | $36.60 | 2 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $23.36 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $21.83 | 1 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $19.53 | 1 | $0 (2018) |
| Vifor Pharma, Inc. | $13.09 | 1 | $0 (2024) |
| Relypsa, Inc. | $12.16 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.10 | 2 | Merck Sharp & Dohme LLC ($33.01) |
| 2023 | $58.66 | 2 | Merck Sharp & Dohme LLC ($58.66) |
| 2022 | $63.45 | 2 | Alexion Pharmaceuticals, Inc. ($41.62) |
| 2019 | $86.51 | 4 | Veloxis Pharmaceuticals, Inc. ($49.91) |
| 2018 | $19.53 | 1 | PORTOLA PHARMACEUTICALS, INC. ($19.53) |
| 2017 | $123.59 | 4 | Keryx Biopharmaceuticals, Inc. ($76.42) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $13.09 | General |
| 07/11/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/02/2023 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/21/2023 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), DIFICID | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/06/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $41.62 | General |
| Category: Rare Disease | ||||||
| 07/23/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Immunosuppressant | ||||||
| 05/09/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/10/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Immunosuppressant | ||||||
| 01/24/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/12/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
| 09/20/2017 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $76.42 | General |
| Category: Nephrology | ||||||
| 04/27/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: NEPHROLOGY | ||||||
| 02/22/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: IMMUNOLOGY | ||||||
| 02/03/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,684 | 4,996 | $1.5M | $202,524 |
| 2022 | 24 | 2,066 | 4,948 | $726,597 | $213,306 |
| 2021 | 21 | 1,591 | 4,340 | $714,877 | $222,081 |
| 2020 | 22 | 1,909 | 4,995 | $782,152 | $211,188 |
Total Patients
7,250
Total Services
19,279
Medicare Billing
$849,100
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 42 | 260 | $509,496 | $69,440 | 13.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 167 | 504 | $333,275 | $44,961 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 102 | 325 | $228,170 | $22,242 | 9.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 25 | 53 | $86,203 | $12,007 | 13.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 71 | 71 | $68,441 | $9,265 | 13.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 34 | $40,198 | $5,510 | 13.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 97 | 431 | $27,308 | $4,442 | 16.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 26 | 39 | $38,439 | $3,945 | 10.3% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 60 | 90 | $22,291 | $3,502 | 15.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 97 | 430 | $20,047 | $3,259 | 16.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 28 | 49 | $19,495 | $2,617 | 13.4% |
| 83735 | Magnesium level | Office | 2023 | 94 | 383 | $15,397 | $2,505 | 16.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 98 | 418 | $12,658 | $2,356 | 18.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $18,026 | $2,330 | 12.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 37 | $16,259 | $2,229 | 13.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 81 | 260 | $4,680 | $2,177 | 46.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 96 | 406 | $12,618 | $2,053 | 16.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 56 | 69 | $12,254 | $1,980 | 16.2% |
| 84100 | Phosphate level | Office | 2023 | 97 | 419 | $11,916 | $1,940 | 16.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 56 | 68 | $5,463 | $892.16 | 16.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Facility | 2023 | 87 | 87 | $8,728 | $741.20 | 8.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 81 | 252 | $3,402 | $552.43 | 16.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 57 | 168 | $3,195 | $517.18 | 16.2% |
| 82610 | Cystatin c (enzyme inhibitor) level | Office | 2023 | 18 | 26 | $2,889 | $471.90 | 16.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 31 | 36 | $2,097 | $342.72 | 16.3% |
About Dr. Kenneth Kokko, M.D
Dr. Kenneth Kokko, M.D is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174533178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Kokko, M.D has received a total of $397.84 in payments from pharmaceutical and medical device companies, with $46.10 received in 2024. These payments were reported across 15 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($397.84).
As a Medicare-enrolled provider, Kokko has provided services to 7,250 Medicare beneficiaries, totaling 19,279 services with total Medicare billing of $849,100. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology, Nephrology
- Location Chattanooga, TN
- Active Since 08/09/2006
- Last Updated 04/16/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1174533178
Products in Payments
- PREVYMIS (Drug) $91.67
- Auryxia (Drug) $76.42
- Envarsus (Drug) $49.91
- ULTOMIRIS (Biological) $41.62
- NATPARA (PARATHYROID HORMONE) (Drug) $36.60
- SAMSCA (Drug) $23.36
- LOKELMA (Drug) $21.83
- BEVYXXA (Drug) $19.53
- Veltassa (Drug) $12.16
- ZORTRESS (Drug) $11.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Nephrology $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Nephrology $2,939
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Nephrology $2,929
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449